Literature DB >> 17466852

Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema.

Güliz Fatma Yavas1, Faruk Oztürk, Tuncay Küsbeci.   

Abstract

PURPOSE: To evaluate the effectiveness of a nonsteroidal antiinflammatory drug (NSAID) on pseudophakic cystoid macular edema (CME) and determine the efficacy when used preoperatively and after uneventful phacoemulsification surgery.
SETTING: Department of Ophthalmology, Kocatepe University, School of Medicine, Afyonkarahisar, Turkey.
METHODS: One hundred seventy-nine eyes of 189 patients having uneventful phacoemulsification surgery were enrolled in the study. After surgery, all patients used topical steroids and antibiotics 4 times daily. Sixty-one eyes, chosen randomly, received a topical NSAID (indomethacin) 4 times daily for 3 days preoperatively and 1 month postoperatively. Sixty eyes received topical indomethacin 4 times daily for 1 month postoperatively. Fifty-eight eyes served as a control group and received only topical steroids and antibiotics. At the third postoperative month, visual acuity, fluorescein angiograms, and macular thresholds were evaluated. Statistical analysis was by chi-square and 1-way analysis of variance tests.
RESULTS: Cystoid macular edema was not seen in the group receiving indomethacin preoperatively and postoperatively. The incidence of angiographic CME was 15.0% in the group receiving postoperative indomethacin and 32.8% in the control group (P<.001). Mean sensitivity in the macular threshold test did not show a significant change between groups (P = .83). Postoperative visual acuity was significantly higher in the group receiving preoperative indomethacin (P<.001).
CONCLUSION: Nonsteroidal antiinflammatory drugs decreased the incidence of CME, and their efficacy increased when begun preoperatively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466852     DOI: 10.1016/j.jcrs.2007.01.033

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  14 in total

1.  Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.

Authors:  Angelo Macrì; Aldo Vagge; Annalisa Salis; Carmen Fucile; Valeria Marini; Antonietta Martelli; Sebastiano Giuffrida; Michele Iester; Gianluca Damonte; Francesca Mattioli
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

2.  Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.

Authors:  Asena Keleş Şahin; Ahmet Şahap Kükner; Fatih Ulaş; Ümit Doğan
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

3.  Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.

Authors:  Nicola Cardascia; Carmela Palmisano; Tersa Centoducati; Giovanni Alessio
Journal:  Int Ophthalmol       Date:  2016-10-20       Impact factor: 2.031

4.  Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.

Authors:  Shan-Shan Li; Hui-Hui Wang; Yan-Ling Wang; Da-Wei Zhang; Xi Chen
Journal:  Int Ophthalmol       Date:  2022-09-06       Impact factor: 2.029

Review 5.  Cataract surgery and nonsteroidal antiinflammatory drugs.

Authors:  Richard S Hoffman; Rosa Braga-Mele; Kendall Donaldson; Geoffrey Emerick; Bonnie Henderson; Malik Kahook; Nick Mamalis; Kevin M Miller; Tony Realini; Neal H Shorstein; Richard K Stiverson; Barbara Wirostko
Journal:  J Cataract Refract Surg       Date:  2016-09       Impact factor: 3.351

6.  Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac.

Authors:  Guadalupe Cervantes-Coste; Yuriana G Sánchez-Castro; Mónica Orozco-Carroll; Erick Mendoza-Schuster; Cecilio Velasco-Barona
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy.

Authors:  Manish Nagpal; Sarang Lambat; Navneet Mehrotra; Gaurav Paranjpe; Harsh Yadav; Sidharth Bhardwaj
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

Review 8.  Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.

Authors:  Viral V Juthani; Elizabeth Clearfield; Roy S Chuck
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

9.  Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

Authors:  Francesco Parmeggiani; Giovanni Sato; Katia De Nadai; Mario R Romano; Andrea Binotto; Ciro Costagliola
Journal:  Curr Genomics       Date:  2011-06       Impact factor: 2.236

Review 10.  Inflammation and macular oedema after pars plana vitrectomy.

Authors:  Vito Romano; Martina Angi; Fabrizio Scotti; Renata del Grosso; Davide Romano; Francesco Semeraro; Paolo Vinciguerra; Ciro Costagliola; Mario R Romano
Journal:  Mediators Inflamm       Date:  2013-10-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.